跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lenzest 25 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lenzest 25
Approved
STANDARD
Lenzest 25
Sun Pharmaceutical Industries Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
78a535d5f7e65368
Company
Sun Pharmaceutical Industries Limited
Type
Standard
Approval Details
Approval Id
78a535d5f7e65368
Drug Approval Philippines Name
Lenzest 25
Product Name
Lenzest 25
Registration Number
DR-XY48492
Brand Name
Lenzest 25
Generic Name
Lenalidomide
Dosage Form
Capsule
Dosage Strength
25 mg
Manufacturer
Sun Pharmaceutical Industries Limited
Importer
Sun Pharma Philippines, Inc.
Distributor
Sun Pharma Philippines, Inc.
Company Detail Path
/organization/sun-pharmaceutical-industries-limited
Issuance Date
24 May 2024
Expiry Date
25 November 2027
Pharmacologic Category
Immunosuppressant
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
78a535d5f7e65368
Type
Standard
Back to Philippines FDA Approvals